Forward Thinking, Experienced, Fresh and Passionate

AvenueBio are on a mission to simplify brand strategy development and planning using the latest academic thinking, practical experience and enabling technologies.
Developing impactful brand strategy, needs teams to work through a well considered, practical set of challenging questions. With advances in digital technology, we believe we can simplify and improve brand strategy development and planning to maximize plan impact and minimize wasted effort.

Alasdair has worked in the pharmaceutical industry for 20 years in strategic marketing and commercial leadership positions. He has worked with both primary and specialist care brands at all stages of the product lifecycle from phase II.

His areas of expertise include launch excellence, strategic planning, supply chain management and tendering and working with clients on the development and execution of brand strategy globally. Alasdair has deep therapy area knowledge in vaccines and immunology, haemato-oncology and oncology, and biosimilars.

Saskia joins AvenueBio with over 25 years’ experience in the pharmaceutical industry, in commercial leadership and strategic marketing roles. She has led global, regional and country organisations across several countries in Europe and the US.

Areas of expertise include strategy development, launch planning and execution, and eco-system shaping. Saskia has deep therapy area knowledge in infectious diseases, vaccines and primary care.

Tracy has more than 15 years of marketing experience in the pharmaceutical industry, from launching and managing brands locally through to strategic marketing consultancy at a regional and global level.

Tracy has worked in primary care and speciality with specific expertise in Brand Planning and Launch Excellence.

Hassan is an experienced life sciences consultant, with expertise spanning drug discovery, manufacturing and commercial roles gained working both in consultancy and on the client side.

His areas of expertise include asset/indication prioritization, asset planning, new product planning, launch excellence and strategic planning, working with clients to support go/no go decisions and on the development of strategy globally. Hassan has deep therapy area knowledge, across immunology, neurology, haemato-oncology and oncology and multiple rare diseases.

Hassan holds a PhD in Biochemistry from Imperial College London.

Lisa is an experienced Pharma Senior Consultant, with more than 25 years in the pharma industry, working across both agency and client roles and across a range of therapy areas.  Her strong analytical and market research background drives a passion for insight gathering, ensuring in-depth market understanding and clarity of unmet needs on which to base strategic decision making.

Having worked closely with payer environments, Lisa has a sound understanding of funding flows and market access considerations. Lisa has worked in primary care and speciality, including rare disease.

Jaimee recently joined the AvenueBio team, having taken a sabbatical with her partner. She is an experienced Brand Manager and has held international and local marketing and sales roles at Janssen, Grunenthal and Vertex.  Jaimee brings expertise and a deep understanding of the challenges of delivering brand growth in international markets.

Jamie joins us from the pharma industry where he led competitive intelligence activities across oncology, neuroscience and rare diseases. He worked with cross-functional teams in local affiliates across many key functions including pre-clinical development, new product and indication launch, established-and-mature product market growth, and loss-of-exclusivity.

Prior to this, Jamie held a senior position at a competitive intelligence consulting agency working with top 10 global pharma clients.

Jamie holds a PhD in Medicinal Chemistry from The Institute of Cancer Research in London.

Guy joins AvenueBio with 12 years’ experience spanning Commercial Strategy, Competitive Intelligence and Market Access consulting, Equity Research and Transaction Advisory, all within the Life Sciences sector. Over the course of his career, Guy has led a variety of commercially – focused projects across a variety of therapy areas, with project types ranging from Brand/Disease Area/Portfolio Strategy (including patient journey modelling, opportunity assessment, positioning and core value claims development) to Market Access Strategy, forecasting and valuation.

Guy holds a MSc in Neuroscience from King’s College, University of London.

Mark has recently joined AvBio having previously worked within competitive intelligence, leading client engagements on competitor threat analyses, market defence strategy development and war-gaming workshops. He offers a thorough and analytical approach with broad experience across many therapeutic areas including in hematological, cardiovascular, metabolic conditions and infectious diseases. Mark holds a PhD in Chemical Engineering from Imperial College London.

Angie has recently joined the AvenueBio team. Previously, she had worked in competitive intelligence for two years, covering a broad range of therapeutic areas, including rare diseases, oncology, immunology and nephrology. Angie has a keen interest in the commercial side of the pharmaceutical industry whilst holding on to her scientific approach in daily practice. Angie holds a PhD in musculoskeletal sciences from the University of Oxford.

Since graduating from Cambridge University in 2017, Katie has been working in the pharmaceutical sector. Katie boasts previous experience in project management from her role in an Oncology CRO and Market Access consulting across the EU5, US and emerging markets. With an intuitive nature, progressive ideas, and engaging communication skills, Katie continually drives projects forward with efficiency and ease.

Prior to joining AvenueBio, Sophie has held researcher and project management roles in competitive intelligence and market research. Through her work, she has supported both big pharma and smaller biotech players to understand market opportunities and inform strategic planning across a range of therapy areas, including immunology, oncology, and infectious and rare diseases.

Sophie holds a First Class MSc in Reproductive Biology from Imperial College London.

Before joining AvenueBio, Pallavi previously worked in life sciences strategy consulting, collaborating with Medical, Commercial and BD teams in both Biotech and Pharma. She has experience in project types such as brand/franchise strategy, scenario planning, patient experience strategy, tactical planning and strategic partnerships in a range of TAs including infectious disease, oncology, inflammation/immunology and rare disease.

Pallavi holds a First Class MSci in Neuroscience from the University of Bristol.

Jessica has worked in healthcare for 19 years, with roles from program development and marketing within a leading university hospital to pharmaceutical medical communications, advertising and strategic consultancy.

Her experience includes deep entrenchment in biotech and pharmaceutical teams, working alongside cross-functional client partners from early clinical development through to commercial life cycle management. Jessica’s career focus has been in oncology with experience on more than 30 unique brands and assets in this space, while also contributing to global and regional efforts for nearly a dozen others in immunology, surgery, and infectious disease.

Russell has worked for over 30 years in various sales, marketing management and customer strategy executive roles across the healthcare, pharmaceutical and consulting business sectors in Australia, USA, UK and Hungary.

He has a passion for marketing excellence, customer-centric thinking and driving strategic choices within a cross-functional team environment. Russell’s particular areas of strength can be seen in critical thinking, expert facilitation, building robust competitive management strategies, as well as developing compelling brand positioning.

He has extensive experience across a wide range of therapy areas including immunology & inflammation, oncology, haematology, ophthalmology, cardio-metabolic disease, infectious diseases and respiratory medicine. Russell has also worked client-side for MSD Australia, Pfizer UK and Pfizer Australia across a variety of senior marketing roles.

Andrew comes to AvenueBio with over six years of experience in the life sciences and pharmaceutical industry.

He previously worked at Takeda UK, where he was part of the business insights team providing support to the Rare Diseases business unit. He has also held various consulting roles, covering the areas of commercial strategy, market access, and M&A (commercial due diligence and strategy).

Andrew is a former GPhC-registered pharmacist, and holds a master’s degree in Pharmacy from UCL.

Peter joins us having graduated with a First Class MSci in Natural Sciences from the University of Exeter in 2023. With a solid academic background, an analytical mind and an inquisitive nature, Peter’s willingness to learn and be challenged brings a fresh perspective to our team.

Anita qualified as an accountant with a big five accountancy practice and has since gained over 25 years’ experience in the pharmaceutical industry. Anita prides herself in running efficient financial processes and providing timely, reliable and accurate financial data to board level management as well as the wider team.

Joanna spent 10 years in The City as an Equity Analyst; initially at UBS and latterly as a Partner at Oriel Securities Ltd on the No.1 ranked Oil & Gas team. During her time at Oriel she also spent time as Head of Client Account Management where she worked on company strategy, internal management information and monitoring. In recent years she has dedicated her time to raising her two sons whilst undertaking a selection of ad hoc jobs, charity work and building projects. Joanna holds a BSc in Mathematics from the University of Leeds.

Miles is an IT professional with over 30 years’ experience. Holding senior roles in software design and development, ICT strategic planning, implementation, and change management – predominantly within the pharmaceutical industry.
As head of Digital at Avenue Bio Consulting, Miles is responsible for creating bespoke and turn-key software solutions designed to complement and add value to Avenue Bio’s client offerings – as well as looking after our day-to-day ICT requirements as a business.

With more than 20 years’ experience in project management and business administration, Claire has supported leading executives in Consultancy, Service Delivery, Strategic Development and Marketing Excellence in both the Defence and Pharmaceutical industries. Providing a highly dedicated, operational support function to the UK team, Claire strives for exceptional results to ensure a seamless delivery of material development, office management, document production and team coordination.

Katie has over 20 years of experience in business administration, project support and customer service. She has supported leading executives in Consultancy, Investment Banking and Leisure industries – providing a highly dedicated operational support and communication function to her teams.

Katie strives for high quality results to ensure a successful project journey, helping with meeting coordination and project management.